CMPX: Compass Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 415.52
Enterprise Value ($M) 378.72
Book Value ($M) 138.40
Book Value / Share 1.01
Price / Book 3.00
NCAV ($M) 130.39
NCAV / Share 0.95
Price / NCAV 3.19

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 31.84
Current Ratio 31.84

Balance Sheet (mrq) ($M)
Current Assets 141.14
Assets 149.15
Liabilities 10.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-16 13G Tang Capital Management Llc
11-14 13G/A Janus Henderson Group Plc 1.30 -75.90
08-02 13G Blackstone Holdings II L.P. 6.90
03-22 13D/A Orbimed Advisors Llc 13.70 0.00
02-09 13G/A Fmr Llc 3.57 -28.38
02-07 13G/A Adage Capital Partners Gp, L.l.c. 7.75 37.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 253,418 1,003,322 25.26
2025-01-30 157,576 685,199 23.00
2025-01-29 682,361 2,071,110 32.95
2025-01-28 935,928 3,910,608 23.93
2025-01-27 238,703 1,498,711 15.93

(click for more detail)

Similar Companies
CLDX – Celldex Therapeutics, Inc. CLNN – Clene Inc.
CLRB – Cellectar Biosciences, Inc. CNSP – CNS Pharmaceuticals, Inc.
CNTX – Context Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io